Limitations of current practices in detection of bacterially contaminated blood products associated with suspected septic transfusion reactions-Reference-Cited by-同舟云学术

Limitations of current practices in detection of bacterially contaminated blood products associated with suspected septic transfusion reactions

Published:2021-06-28 Issue:8 Volume:61 Page:2414-2420
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Martin Isabella W.¹^ORCID,Cohn Claudia S.²^ORCID,Delaney Meghan³⁴,Fontaine Magali J.⁵^ORCID,Shih Andrew W.⁶⁷^ORCID,Dunbar Nancy M.¹^ORCID,Dagger John,Fadeyi Emmanuel A.,Flanagan Peter,Gathof Birgit,Godbey Elizabeth A.,Harach Mary,Huggins Y. Monique,Ipe Tina S.,Jackson Bryon,Jacquot Cyril,Jin Zhongbo,Jones Mary Rose,Kamel Hany,Karp Julie K.,Lewin Antoine,Mo Yunchuan,Murphy Mike,O'Brien Jennifer,Ommer Katharina,Pagano Monica B.,Passwater Michael,Pelletier J. Peter R.,Robillard Pierre,Schwartz Joseph,Sham Lawrence,Shunkwiler Sara M.,Simmons Julie S.,Staves Julie,Takanaski Minoko,Weiss Susan,Williams Shelly M.,Yamada Chisa,Young Pampee P.,Ziman Alyssa,

Affiliation:

1. Department of Pathology and Laboratory Medicine Dartmouth‐Hitchcock Medical Center Lebanon New Hampshire USA

2. Department of Laboratory Medicine and Pathology University of Minnesota Minneapolis Minnesota USA

3. Department of Pathology and Laboratory Medicine Children's National Hospital Washington District of Columbia USA

4. Department of Laboratory Medicine University of Washington, Seattle Children's Hospital Seattle Washington USA

5. Department of Pathology University of Maryland School of Medicine Baltimore Maryland USA

6. Department of Pathology and Laboratory Medicine University of British Columbia Vancouver British Columbia Canada

7. Vancouver Coastal Health Authority Vancouver British Columbia Canada

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16545

Reference19 articles.

1. Blood Safety in the United States: Prevention, Detection, and Pathogen Reduction

2. US Food and Drug Administration.Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion: guidance for industry.2019.https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bacterial-risk-control-strategies-blood-collection-establishments-and-transfusion-services-enhance

3. U.S. Centers for Disease Control and Prevention.The National Healthcare Safety Network (NHSN) manual: biovigilance component v2.5 2021.http://www.cdc.gov/nhsn/PDFs/Biovigilance/BV‐HV‐protocol‐current.pdf. Accessed 12 Jan 2021.

4. SherG MarkowitzM.AABB Association Bulletin #14–04. Clinical recognition and investigation of suspected bacterial contamination of platelets.2014.

5. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consent and an approach to the management of acute and chronic transfusion reactions;Hemostasis Management of the Pediatric Surgical Patient;2024

2. Associated criteria used in investigating suspected septic transfusion reactions: A scoping review;Vox Sanguinis;2023-09-11

3. Intensity of endogenous thrombocytopenia after autologous stem cell transplantation in patients prophylactically transfused with platelets;Vox Sanguinis;2023-05-22

4. Blood Transfusion Reactions—A Comprehensive Review of the Literature including a Swiss Perspective;Journal of Clinical Medicine;2022-05-19

5. Application of Standardized Residual Component Culture Criteria for Suspected Septic Transfusion Reactions Would Increase the Component Culturing Rate at a Single Academic Medical Center;American Journal of Clinical Pathology;2022-03-21